نتایج جستجو برای: anticoagulant
تعداد نتایج: 13476 فیلتر نتایج به سال:
Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.
The main complication of anticoagulant therapy is bleeding. Although the use of long-term oral anticoagulants in patients with transient cerebral ischemia and/or minor stroke is controversial, anticoagulants are still used in some instances. We have carried out a literature review of the risk of hemorrhage during long-term oral anticoagulant therapy in patients with cerebrovascular disease to d...
BACKGROUND A high incidence of both arterial and venous thromboembolic events has been reported in patients with systemic lupus erythematosus (SLE), but the risks and benefits of primary prophylactic antithrombotic therapy have not been assessed. We measured the clinical benefit of 3 antithrombotic regimens in patients with SLE without antiphospholipid antibodies, with anticardiolipin antibodie...
THE COMMON USE of anticoagulant drugs in the treatment of thrombotic manifestations has increased the awareness of resulting complications, notably bleeding from the gastrointestinal and the genitourinary tracts. The incidence of such complications has been estimated between 2 and 19 per cent.' Fatal hemorrhage in a series of 1,091 patients was 0.5 per cent.2 3 When a hemorrhage occurs, it is u...
Venous thromboembolism remains a frequent cause of vascular death. Despite advances in anticoagulant drug development, unmet needs remain, including limited treatment options for patients with severe renal impairment and the inability to fully reverse the effects of anticoagulants approved or in late-stage development. Because coagulation factor IXa plays a pivotal role in tissue factor-mediate...
THE COMMON USE of anticoagulant drugs in the treatment of thrombotic manifestations has increased the awareness of resulting complications, notably bleeding from the gastrointestinal and the genitourinary tracts. The incidence of such complications has been estimated between 2 and 19 per cent.' Fatal hemorrhage in a series of 1,091 patients was 0.5 per cent.2 3 When a hemorrhage occurs, it is u...
BACKGROUND Intracranial hemorrhage is the most feared complication of oral anticoagulant treatment. The optimal treatment option for patients with atrial fibrillation who survive an intracranial hemorrhage remains unknown. We hypothesized that restarting oral anticoagulant treatment was associated with a lower risk of stroke and mortality in comparison with not restarting. METHODS AND RESULTS...
Activation of human platelets considerably enhanced their ability to accelerate factor Va inactivation by activated protein C (APC). The anticoagulant activity of platelet suspensions was markedly dependent on the kind of agonist used to activate platelets. APC-catalyzed factor Va inactivation in free solution was characterized by an apparent second-order rate constant of 2 x 10(5) (mol/L)-1 (s...
Recent studies have demonstrated that protein C deficiency is associated with recurrent familial thrombosis. In plasma, activated protein C functions as an anticoagulant. This anticoagulant response requires a vitamin K-dependent plasma protein cofactor, referred to as protein S. Since the anticoagulant activity of activated protein C is dependent on protein S, we hypothesized that patients lac...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید